Home > Category > Signaling Pathways > Cytoskeletal Signaling > Integrin > Etrolizumab (Anti-Integrin α4β7) (ITGA4 & ITGB7)

Etrolizumab (Anti-Integrin α4β7) (ITGA4 & ITGB7)

ChemLeader 95+%

Catalog No：CLA1265 CAS No.：1044758-60-2 MDLNo： Formula： MW：

Collect Share

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
1 mg	3-5days	$1500.00	Visible after login	- +
5 mg	3-5days	$5100.00	Visible after login	- +
10 mg	3-5days	$9700.00	Visible after login	- +

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry Add To Cart

Product Overview
Related documents
Product details
Related literature

Product Overview

Product Name	Etrolizumab (Anti-Integrin α4β7) (ITGA4 & ITGB7)
CAS	1044758-60-2
Storage condition	Store at 2 to 8 °C for 1-2 weeks. Store at -20 °C for 12 months. Store at -80 °C for long term storage. Use a manual defrost freezer and avoid repeated freeze-thaw cycles, away from light.

Product details

Etrolizumab (rhuMAb Beta7) is a gut-selective, anti- β7 integrin monoclonal antibody. Etrolizumab is specific targeting of the β7 subunit of α4β7 and αEβ7 integrins with K i values of 18 nM and 1800 pM for Human α4β7 and Human αEβ7-293, respectively. Etrolizumab can be used in research of inflammatory bowel disease (IBD).

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History

CLA1265

Etrolizumab (Anti-Integrin α4β7) (ITGA4 & ITGB7)

1044758-60-2 95+%